Liesbeth Ras

Liesbeth Ras currently serves as the Head of Medical at Sandoz Nederland, where she plays a pivotal role in shaping the company's medical strategy and advancing its mission to deliver innovative healthcare solutions. In this capacity, Liesbeth leads a dynamic Medical Affairs team, navigating an environment characterized by rapid change and evolving regulatory landscapes. Her leadership emphasizes fostering a collaborative, high-performance culture, ensuring that cross-functional initiatives—spanning pharmacovigilance, regulatory affairs, and clinical development—are seamlessly integrated to optimize patient outcomes and support the company's strategic objectives.

With a strong foundation in pharmacovigilance and regulatory affairs, Liesbeth has a proven track record of managing complex projects related to drug safety, clinical trial oversight, and pharmaceutical compliance. Her expertise extends to areas such as oncology research, cancer immunotherapy, and allergic rhinitis, allowing her to bring a comprehensive understanding of therapeutic areas that are critical to Sandoz’s pipeline and portfolio. She is deeply committed to recruitment, talent development, and continuous learning, ensuring her team remains agile and well-equipped to handle the challenges of the pharmaceutical industry.

Liesbeth’s strategic mindset and operational acumen enable her to implement process optimizations and drive impactful initiatives across the organization. Her servant leadership style fosters an environment of trust and innovation, empowering her team to deliver high-quality medical insights and support the company’s goal of improving patient care. Her expertise in project management, combined with her focus on multidisciplinary collaboration, positions her as a key driver of Sandoz Nederland’s success in a competitive and rapidly evolving healthcare landscape.